Influence of the Breast Tumor Stromal Fibroblasts on Immunological Processes In Vitro

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• Tumor stroma plays a critical role in cancer progression and immune evasion.
• Fibroblasts within the tumor microenvironment are key cellular components influencing immune responses.

Purpose of the Study:

• To investigate the in vitro effects of breast cancer-associated fibroblasts (CAFs) on dendritic cell (DC) differentiation and maturation.
• To assess the impact of CAFs on T lymphocyte proliferation.
• To understand the role of CAFs in modulating adaptive immunity in breast cancer.

Main Methods:

• Isolation and culture of stromal cells from breast cancer tissue.
• Characterization of cultured cells using fibroblast and immune cell markers (CD73, CD90, CD44, CD10, CD29, HLA-ABC, CD326, CD24, CD68).
• Assessment of fibroblast activation markers (FAP, tenascin C, α-SMA).
• In vitro co-culture assays to evaluate DC differentiation/maturation and T lymphocyte proliferation.

Main Results:

• Isolated stromal cells exhibited fibroblast-like morphology and expressed mesenchymal markers (CD73, CD90) and activation markers (FAP, tenascin C, α-SMA), confirming their activated fibroblast origin.
• These CAFs significantly suppressed the differentiation of dendritic cells from monocytes.
• CAFs also inhibited the proliferation of T lymphocytes but did not affect DC maturation.

Conclusions:

• Fibroblasts within the breast cancer stroma possess immunosuppressive properties.
• CAFs can impair crucial adaptive immune mechanisms, including DC differentiation and T cell responses.
• These findings suggest that CAFs contribute to tumor immune escape by suppressing anti-tumor immunity.